TESE DE MESTRADO.pdf - Ubi Thesis

11 - Kim S, Park S, Shin I, Choe J. Anticiclic Citrullinated Peptide Antibody, Smoking, Alcohol
Consumption, and Disease Duration as Risk Factors for Extraarticular Manifestations in Korean
Patients with Rheumatoid Arthritis. J Rheumatol 2008 Jun;35(6):995-1001.
12 - Melo FM. Análise da correlação dos escores de atividade de doença na artrite reumatóide.
Florianópolis; 2008
13 - Guillemin F. How to assess musculoskeletal conditions. Assessment of disease activity.
Best Pract Res Clin Rheumatol 2003 Jun;17(3):415-26.
14 - Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical
Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S100-8.
15 - Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Clin
Exp Rheumatol 2005;23(Suppl. 39):93-9.
16 - Prevoo ML, van Hof MA, Kupper HH, van Leeuwen MA, van de Putte LB, van Riel PL.
Modified disease activity scores that include twenty-eight-tjoint counts. Arthritis and
Rheumatism 1995 Jan;38(1):44-8.
17 - van Riel PL, Fransen J. Established rheumatoid arthritis: clinical assessments. Best
Pract Res Clin Rheumatol. 2007 Oct;21(5):807-25.
18 - Emery P, Gabay C, Kraan M, Reino JG. Evidence-based review of biologic markers as
indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int 2007
May;27:793-806.
19 - Plant MJ, Williams AL, O’Sullivan MM, Lewis PA, Coles EC, Jessop JD. Relationship
between time-integrated C-Reactive Protein levels and radiologic progression in patients with
Rheumatoid Arthritis. Arthritis and Rheumatism. 2000 Jul;43(7):1473-7.
20 - Dessein PH, Joffe BI, Stanwix AE. High Sensitivity C-reactive protein as a Disease
Activity Marker in Rheumatoid Arthritis. 2004 Jun;31(6):1095-7.
38